BFRA - Biofrontera AG

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

Currency in EUR. All numbers in thousands
Total Revenue21,10712,0256,1304,138
Cost of Revenue4,4511,7151,6521,236
Gross Profit16,65610,3104,4782,902
Operating Expenses
Research Development4,4274,2254,6406,204
Selling General and Administrative30,70720,01911,6176,929
Non Recurring----
Total Operating Expenses39,58525,95917,90914,369
Operating Income or Loss-18,478-13,934-11,779-10,231
Income from Continuing Operations
Total Other Income/Expenses Net-791-2,1681,200-972
Earnings Before Interest and Taxes-18,478-13,934-11,779-10,231
Interest Expense-1,784-1,133-1,207-1,168
Income Before Tax-19,269-16,102-10,579-11,203
Income Tax Expense-10,391---
Minority Interest----
Net Income From Continuing Ops-8,878-16,102-10,579-11,203
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-8,878-16,102-10,579-11,203
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-8,878-16,102-10,579-11,203